Director, Institute for Cancer Research, Oslo University Hospital; Group Leader, Dept. of Cancer Immunol; Professor, Inst. Clinical Medicine, University of Oslo
Stort engasjement på Symposium om offentlig tjenesteinnovasjon på @DNVA1 denne uken. Hva kjennetegner offentlig tjenesteinnovasjon? Hvordan sette i gang endringsprosesser? Takk til @KjetilTasken for en fantastisk dag👏
matrix-fkb.no/no/aktuelt/sto…
Sverige "ska inte vara landet lagom" sier Utbildningsminister Johan Pehrson og annonserer 600 mill kr til life science og helse. I Norge kuttes det i FoU og til sektoren. Er vi i Norge "landet lagom" som legger oss bak i feltet i Europa mhp FoU-satsning?
lifesciencesweden.se/article…?
I Sverige sier utdanningsministeren "Vi vet att den här sektorn [livsvitenskap og helse] de facto står för 10 procent av Sveriges export och är en av våra viktiga basnäringar". Også i Norge er helse erklært en eksportnæring... @Regjeringen @DNVA1 @UniOslo
Very happy about this funding by #Kreftforeningen, enabling us to continue our program i-tumor immunity by perturbing regulatory T-cell function with small molecules. Exciting times ahead!
We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society
👏 We are excited that two projects connected to MATRIX are funded and congratulate @HellandAslaug, @KjetilTasken and their research teams: matrix-fkb.no/en/news/two-ma…
We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society
👏 We are excited that two projects connected to MATRIX are funded and congratulate @HellandAslaug, @KjetilTasken and their research teams: matrix-fkb.no/en/news/two-ma…
Outstanding research environments take years to build and only a few budget decisions to tear down, it can literally be done in days... See what we write about this years budget by @Regjeringen from @DNVA1. By reducing investments in R&D we are doing the opposite of Europe.
Vi er svært glade for tildelingene fra @forskningsradet i dag, som bla. gir midler til å forsette å jobber med celle-genterapi, samt til forprosjekt for protonterapi.
1,3 milliardar kroner til forskingsinfrastruktur (forskningsradet.no)
Attending #ESMO24?
Interested in how the DRUP-like clinical trials are sharing clinical data across borders? Don't miss our poster presentation🗓️15th September 12-13, where we describe how we share clinical outcome data from the different DRUP-like clinical trials. See you there!
Thank’s to all the organizers for two fantastic days at the Norwegian Cancer Symposium, marking the 70th aniversary of the ICR! Inspiring talks, good discussions, two vibrant poster sessions with almost 200 posters as well as delicious food👏👏👏
What a great start for the Norwegian Cancer Symposium by Prof. Douglas Hanahan @EPFL ! #HallmarksofCancer We are also celebrating the 70th anniversary of our Institute for Cancer Research at The Norwegian Radium Hospital 🥳🎉🇳🇴🇳🇴🇳🇴@Oslounivsykehus!
Celebrating 70 years of the Institute for Cancer Research @OusResearch
with great invited speakers, short talks and posters. Kicked off by an update on the Hallmarks of cancer by Prof. Douglas Hanahan.
@CanCell_UiO@Oslounivsykehus
The Norwegian Cancer Symposium 2024 is marking the 70th anniversary of Institute for Cancer Research at @Oslounivsykehus.
Keynote speaker #DouglasHanahan kicked-off the scientific program with an excellent talk about Hallmarks of Cancer 2024.
Norwegian Cancer Symposium, Sept 9-10, 2024, celebrating 70 years of #CancerResearch at Institute for Cancer Research, @Oslounivsykehus, starts with >430 participants, speakers & invited guests. Look forward to talks by 15 invited speakers, 8 short talk speakers, and 118 posters.